The NemetzGroup LLC

Reflections on the Path Ahead

Susan Nemetz — Wed, 28 Oct 2026 20:51:40 +0000

There’s an old saying I’m sure you are familiar with… the cobbler’s children have no shoes. Many entrepreneurs can relate to that sentiment.

The post Reflections on the Path Ahead appeared first on The NemetzGroup LLC.

Designing for Credibility in Biopharma

Melinda Fayette — Tue, 29 Sep 2026 17:13:51 +0000

Biopharma companies have complicated stories to tell. The science is complex, the data is evolving, and different audiences need different information.

The post Designing for Credibility in Biopharma appeared first on The NemetzGroup LLC.

Service Provider Sprawl and the Case for Integrated Commercialization

Susan Nemetz — Thu, 27 Aug 2026 00:16:00 +0000

No two commercialization plans look the same. Unlike other key functions that operate with disciplined processes and a clear sequence of activities (e.g., clinical operations, regulatory affairs), commercialization must be tailored to a company’s aspirations, team resources, and capabilities, as well as whatever market dynamics are in play.

The post Service Provider Sprawl and the Case for Integrated Commercialization appeared first on The NemetzGroup LLC.

Summer Rhythm: Getting Ready for Fall

Liz Tufo — Tue, 28 Jul 2026 20:24:21 +0000

Things get pretty intense in the fall. Timelines tighten, board meetings intensify, and decision velocity accelerates. That’s why, after years working in biopharma, I have come to believe that the absolute best preparation for what’s coming is enjoying the summer!

The post Summer Rhythm: Getting Ready for Fall appeared first on The NemetzGroup LLC.

The Identity Crisis at the Heart of Medical Affairs

Alf Bernhardt, MD — Wed, 24 Jun 2026 02:03:17 +0000

Medical Affairs — the function that translates clinical evidence for physicians, payers, and regulators — has been demonstrating its value for decades. The problem is not evidence. It is power.

The post The Identity Crisis at the Heart of Medical Affairs appeared first on The NemetzGroup LLC.

Your Launch Plan Is Ready. Your Launch Team Isn’t.

Kristin Owens — Tue, 19 May 2026 18:37:46 +0000

Most biotech leaders understand that launch preparation, building the plan, begins well before expected approval. That's not the problem we see.

The post Your Launch Plan Is Ready. Your Launch Team Isn’t. appeared first on The NemetzGroup LLC.

Process Unleashes Innovation

Colleen Moore — Wed, 22 Apr 2026 01:57:57 +0000

Strategic planning within a company must be interconnected, with a clear hierarchy that aligns every effort with the overarching vision and mission.

The post Process Unleashes Innovation appeared first on The NemetzGroup LLC.

Mind vs. Machine in Asset Strategy

Jim Whalen — Tue, 24 Mar 2026 19:59:21 +0000

A well-informed asset strategy is an essential component of developing a novel therapy to meet critical patient needs.

The post Mind vs. Machine in Asset Strategy appeared first on The NemetzGroup LLC.

Medical Affairs Today

Susan Nemetz — Wed, 25 Feb 2026 02:25:08 +0000

The biggest risk for pre-commercial companies is being singularly focused on a lean development program without planning for the additional data needed to support favorable pricing, clinical practice, and long-term market success. Early investment in medical affairs expertise is essential. Even a single FTE or experienced medical affairs consultant pays significant dividends later.

The post Medical Affairs Today appeared first on The NemetzGroup LLC.

The Right Forum, at the Right Time

Liz Tufo — Wed, 28 Jan 2026 02:30:58 +0000

Some people need to “think out loud.” Others are eager to get right to the point. Toss in challenging schedules and countless communication platforms at our fingertips — a reality amplified by today's hybrid and virtual work environments — and the decision doesn’t get any easier. And, of course, this is unlikely to get better as more “content” is created in seconds due to the proliferation of AI.

The post The Right Forum, at the Right Time appeared first on The NemetzGroup LLC.